SWK Holdings Corp (SWKH) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues:
Finance receivable interest income, including fees	9.3	9.3	9.7	8.5	6.8	10.4	9.5	9.4
Pharmaceutical development	0.2	0.1	0.0	5.1	0.1	0.2	5.3	0.2
Other	0.0	0.0	0.1	0.0		0.5	0.2
Total revenues	9.5	9.4	9.8	13.6	6.9	11.1	15.0	9.6
Total revenues growth	36.8%	-15.5%	-34.5%	42.4%	-68.8%	18.8%	37.3%	-10.2%
Costs and expenses:
Provision (benefit) for credit losses	-0.7
Interest expense	-0.4	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1
Pharmaceutical manufacturing, research and development expense	1.5	0.7	1.8	1.8	1.5	1.9	1.8	2.5
Depreciation and amortization expense	0.6	0.6	0.6	0.6	0.6	0.7	0.8	0.8
General and administrative	3.0	2.5	2.4	4.3	3.0	3.2	3.8	3.6
Income from operations	9.8	5.3	14.8	6.8	6.9	11.1	12.3	6.9

Other income (expense), net
Unrealized net gain (loss) on warrants	0.4	-1.0	-0.2	1.8	-0.5	-0.7	-0.4	-0.2
Unrealized net loss on equity securities					-0.5	0.0

Gain on foreign currency transactions
Income before income tax expense	5.4	4.5	-4.4	8.6	0.7	4.6	8.4	2.8
Income tax expense	1.5	-0.1	-7.2	1.9	0.2	1.1	2.1	0.5
Tax rate	27.0%		164.7%	22.7%	24.4%	23.8%	24.9%	18.6%
Net income	3.9	4.6	2.8	6.6	0.6	3.5	6.3	2.2

Net income per share
Basic	$0.31	$0.36	$0.22	$0.52	$0.04	$0.27	$0.50	$0.18
Diluted	$0.31	$0.36	$0.22	$0.51	$0.04	$0.27	$0.49	$0.17

Basic	12.7	12.8	12.8	12.8	12.8	12.8	12.8	12.8
Diluted	12.8	12.9	12.9	12.9	12.9	12.9	12.8	12.9